Yu-waye Chu - Net Worth and Insider Trading
Yu-waye Chu Net Worth
The estimated net worth of Yu-waye Chu is at least $496,870 dollars as of 2025-07-04. Yu-waye Chu is the Chief Medical Officer of CytomX Therapeutics Inc and owns about 135,725 shares of CytomX Therapeutics Inc (CTMX) stock worth over $339,313. Yu-waye Chu is also the Chief Medical Officer of Fate Therapeutics Inc and owns about 140,676 shares of Fate Therapeutics Inc (FATE) stock worth over $157,557. Details can be seen in Yu-waye Chu's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Yu-waye Chu has not made any transactions after 2025-03-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Yu-waye Chu
Yu-waye Chu Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Yu-waye Chu owns 2 companies in total, including Fate Therapeutics Inc (FATE) , and CytomX Therapeutics Inc (CTMX) .
Click here to see the complete history of Yu-waye Chu’s form 4 insider trades.
Insider Ownership Summary of Yu-waye Chu
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| FATE | Fate Therapeutics Inc | 2023-04-18 | See Remarks |
| CTMX | CytomX Therapeutics Inc | 2025-03-18 | Chief Medical Officer |
Yu-waye Chu Latest Holdings Summary
Yu-waye Chu currently owns a total of 2 stocks. Among these stocks, Yu-waye Chu owns 135,725 shares of CytomX Therapeutics Inc (CTMX) as of March 18, 2025, with a value of $339,313 and a weighting of 68.29%. Yu-waye Chu also owns 140,676 shares of Fate Therapeutics Inc (FATE) as of April 18, 2023, with a value of $157,557 and a weighting of 31.71%.
Latest Holdings of Yu-waye Chu
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2025-03-18 | 135,725 | 2.50 | 339,313 |
| FATE | Fate Therapeutics Inc | 2023-04-18 | 140,676 | 1.12 | 157,557 |
Holding Weightings of Yu-waye Chu
Yu-waye Chu Form 4 Trading Tracker
According to the SEC Form 4 filings, Yu-waye Chu has made a total of 1 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in CytomX Therapeutics Inc is the sale of 4,025 shares on March 18, 2025, which brought Yu-waye Chu around $2,415.
According to the SEC Form 4 filings, Yu-waye Chu has made a total of 6 transactions in Fate Therapeutics Inc (FATE) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Fate Therapeutics Inc is the sale of 2,532 shares on April 18, 2023, which brought Yu-waye Chu around $16,635.
Insider Trading History of Yu-waye Chu
- 1
Yu-waye Chu Trading Performance
Yu-waye Chu Ownership Network
Ownership Network List of Yu-waye Chu
Ownership Network Relation of Yu-waye Chu
Yu-waye Chu Owned Company Details
What does Fate Therapeutics Inc do?
Who are the key executives at Fate Therapeutics Inc?
Yu-waye Chu is the See Remarks of Fate Therapeutics Inc. Other key executives at Fate Therapeutics Inc include Chief Development Officer Bahram Valamehr , See Remarks Cindy Tahl , and director & 10 percent owner Redmile Group, Llc .
Fate Therapeutics Inc (FATE) Insider Trades Summary
Over the past 18 months, Yu-waye Chu made no insider transaction in Fate Therapeutics Inc (FATE). Other recent insider transactions involving Fate Therapeutics Inc (FATE) include a net purchase of 56,331 shares made by Redmile Group, Llc , a net sale of 19,976 shares made by Bahram Valamehr , and a net sale of 16,528 shares made by Cindy Tahl .
In summary, during the past 3 months, insiders sold 0 shares of Fate Therapeutics Inc (FATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 408,018 shares of Fate Therapeutics Inc (FATE) were sold and 397,964 shares were bought by its insiders, resulting in a net sale of 10,054 shares.
Fate Therapeutics Inc (FATE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fate Therapeutics Inc Insider Transactions
Yu-waye Chu Mailing Address
Above is the net worth, insider trading, and ownership report for Yu-waye Chu. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Yu-waye Chu's mailing address is: San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
